|
"meric bernstam f"的相关文件
显示项目 1-9 / 9 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2024-06-17 |
Plain language summary of the FOENIX-CCA2 study: Futibatinib for people with advanced bile duct cancer
|
Goyal, L; Meric-Bernstam, F; Hollebecque, A; Valle, JW; Morizane, C; Karasic, TB; Abrams, TA; Furuse, J; Kelley, RK; Cassier, PA; Klümpen, HJ; Chang, HM; Chen, LT; Tabernero, J; Oh, D; Mahipal, A; Moehler, M; Komatsu, Y; Ahn, DH; Epstein, RS; Halim, AB; Wacheck, V; He, YH; Liu, M; Benhadji, KA; Bridgewater, JA |
| 國家衛生研究院 |
2023-01-19 |
Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma
|
Goyal, L; Meric-Bernstam, F; Hollebecque, A; Valle, JW; Morizane, C; Karasic, TB; Abrams, TA; Furuse, J; Kelley, RK; Cassier, PA; Klümpen, HJ; Chang, HM; Chen, LT; Tabernero, J; Oh, DY; Mahipal, A; Moehler, M; Mitchell, EP; Komatsu, Y; Masuda, K; Ahn, D; Epstein, RS; Halim, AB; Fu, Y; Salimi, T; Wacheck, V; He, Y; Liu, M; Benhadji, KA; Bridgewater, JA |
| 國家衛生研究院 |
2022-06 |
Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements
|
Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, PA;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, DH;Li, K;Benhadji, KA;Wacheck, V;Bridgewater, JA |
| 國家衛生研究院 |
2021-09 |
Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
|
Mohler, M;Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, P;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, D;He, Y;Soni, N;Benhadji, KA;Bridgewater, JA |
| 國家衛生研究院 |
2021-07 |
Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
|
Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, P;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, D;He, YH;Soni, N;Benhadji, KA;Bridgewater, JA |
| 中國醫藥大學 |
2010 |
Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.
|
(Luyimbazi D.); (Akcakanat A.); (McAuliffe P. F.); (Zhang L.); (Singh, G); (Gonzalez-Angulo, A. M); (Chen, H.); (Do, K. A.); (Zheng Y.); 洪明奇(Mien-Chie Hung); (Mills, G. B); (Meric-Bernstam F)* |
| 亞洲大學 |
2007-10 |
Rapamycin regulates the phosphorylation of rictor
|
Akcakanat, A.;Singh, G.;Mien-Chie Hung;Meric-Bernstam F |
| 亞洲大學 |
2004-10 |
Targeting mTOR synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.
|
Mondesire, W. H.;Jian, W.;Zhang, H.;Ensor, J.;Mien-Chie Hung;Mills, G. B.;Meric-Bernstam, F |
| 亞洲大學 |
2004-02 |
Determinants of rapamycin sensitivity in breast cancer cells
|
Noh, W.-C.;Mondesire, W. H.;Peng, J.;Jian, W.;Zhang, H.;Dong, J.;Mills, G. B.;Mien-Chie Hung;Meric-Bernstam, F. |
显示项目 1-9 / 9 (共1页)
1
每页显示[10|25|50]项目
|
